Sunno Biotech: Obtained a commitment of 270 million yuan in special loans for stock repurchases from CITIC Bank.

Sanuo Biologics announced that on March 27, 2026, the company approved a share repurchase plan with a repurchase fund of 1.5 billion to 3 billion, to be used for canceling and reducing registered capital. Recently, the company obtained a loan commitment letter from Changsha Branch of China Citic Bank, with a loan amount not exceeding 270 million, a term not exceeding 3 years, specifically for repurchasing company shares. The commitment letter is valid for 1 year. This matter does not constitute a related party transaction or a major asset restructuring, does not affect business performance, and the specific repurchase amount will be based on actual conditions.